Empery Asset Management, LP 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-28 2:25 pm Sale | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Empery Asset Management, LP | 4,022 3.900% | -2,228 (-35.65%) | Filing |
| 2020-08-04 09:18 am Purchase | 2020-07-30 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Empery Asset Management, LP | 6,250 6.900% | 6,250 (New Position) | Filing |